FDA advisers raise doubts about switch to annual Covid boosters
A Food and Drug Administration (FDA) advisory committee on Thursday raised questions about the shift to an annual Covid booster for most adults and children, saying too many questions remain about the unresponsive virus. The FDA convened its Advisory Committee on Vaccines and Related Biologicals to discuss how Covid vaccines may change in the future.On Monday, the agency published information documents proposing annual covid vaccines that target the latest variants of the virus, a similar approach to the annual flu shot.But during Thursday's meeting, several committee members said they were worried about making decisions about when to administer the vaccines,…
